The TLR9 agonist (GNKG168) induces a unique immune activation pattern in vivo in children with minimal residual disease positive acute leukemia: Results of the TACL T2009-008 phase I study

Ras and exosome signaling

(2019) Rachel E. Sexton et al.   SEMINARS IN CANCER BIOLOGY

Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer

(2018) Daniel O Villarreal et al.   CANCER RESEARCH

Soluble Interleukin-7 receptor levels and risk of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

(2018) Katrine Kielsen et al.   CLINICAL IMMUNOLOGY

Chemokines and cancer: new immune checkpoints for cancer therapy

(2018) Nathan Karin   CURRENT OPINION IN IMMUNOLOGY

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

(2018) Miliotou N. Androulla et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

(2018) Shannon L. Maude et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Chemokine Receptor CCR8 Promotes the Migration of Dendritic Cells into the Lymph Node Parenchyma to Initiate the Allergic Immune Response

(2018) Caroline L. Sokol et al.   IMMUNITY

Suppression of inflammation and acquired immunity by IL-37

(2017) Giulio Cavalli et al.   IMMUNOLOGICAL REVIEWS

Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8

(2017) Martina Molgora et al.   IMMUNOLOGICAL REVIEWS

CD56 bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections

(2017) Chelsey J. Judge et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance

(2017) Giulio Cavalli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CCR8+FOXp3+Tregcells as master drivers of immune regulation

(2017) Yiftah Barsheshet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Promyelocytic Leukemia Protein Is an Essential Regulator of Stem Cell Pluripotency and Somatic Cell Reprogramming

(2017) Christiana Hadjimichael et al.   Stem Cell Reports

Transcriptome analysis reveals similarities between human blood CD3− CD56bright cells and mouse CD127+ innate lymphoid cells

(2017) David S. J. Allan et al.   Scientific Reports

Expression and function of IL-1R8 (TIR8/SIGIRR), a regulatory member of the IL-1 receptor family in platelets

(2016) Achille Anselmo et al.   CARDIOVASCULAR RESEARCH

Suppression of innate inflammation and immunity by interleukin-37

(2016) Charles A. Dinarello et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Retinoic acid-induced IgG production in TLR-activated human primary B cells involves ULK1-mediated autophagy

(2015) Agnete Bratsberg Eriksen et al.   Autophagy

Acute Lymphoblastic Leukemia in Children

(2015) Stephen P. Hunger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7R  Dependent

(2015) C. B. Johnson et al.   Cancer Immunology Research

The human long noncoding RNA lnc-IL7R regulates the inflammatory response

(2014) Huachun Cui et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Differential Expression of the Human CD8  Splice Variants and Regulation of the M-2 Isoform by Ubiquitination

(2014) D. Thakral et al.   JOURNAL OF IMMUNOLOGY

Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages

(2014) Tomoyuki Oshio et al.   PLoS One

Murine Mast Cells Secrete and Respond to Interleukin-33

(2013) Hui-Ying Tung et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

The Human CD8β M-4 Isoform Dominant in Effector Memory T Cells Has Distinct Cytoplasmic Motifs That Confer Unique Properties

(2013) Deepshi Thakral et al.   PLoS One

Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by Prostate Cancer Cell-Associated Exosomes

(2013) Zakaria Y. Abd Elmageed et al.   STEM CELLS

Targeting ST2L Potentiates CpG-Mediated Therapeutic Effects in a Chronic Fungal Asthma Model

(2011) Hemanth Ramaprakash et al.   AMERICAN JOURNAL OF PATHOLOGY

CpG oligodeoxynucleotides induce strong up-regulation of interleukin 33 via Toll-like receptor 9

(2010) Takeshi Shimosato et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

Distinctive CD3 Heterodimeric Ectodomain Topologies Maximize Antigen-Triggered Activation of    T Cell Receptors

(2010) S. T. Kim et al.   JOURNAL OF IMMUNOLOGY

SIGIRR inhibits toll-like receptor 4, 5, 9-mediated immune responses in human airway epithelial cells

(2010) Chun Zhang et al.   MOLECULAR BIOLOGY REPORTS

Novel postremission strategies in adults with acute myeloid leukemia

(2009) Jeffrey E Lancet et al.   CURRENT OPINION IN HEMATOLOGY

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

(2008) M. J. Borowitz et al.   BLOOD

Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapse

(2008) Nobuko Hijiya et al.   CANCER

Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

(2008) Elizabeth A. Raetz et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

(2008) Peter Bader et al.   JOURNAL OF CLINICAL ONCOLOGY